Released May 13, 2011, during market hours
10-Q filed May 13, 2011, 43 days after period end · 0001019687-11-001627
Q1 2011 · 10-Q
Revenue$6.00M$6.00M no prior Q1 2010 on fileno prior Q4 2010 on file
Net Income-$559.00K-$559.00K no prior Q1 2010 on fileno prior Q4 2010 on file
EPS Diluted-$0.01-$0.01 no prior Q1 2010 on fileno prior Q4 2010 on file
Operating Income-$520,000—
Operating Cash Flow$904,000—
Free Cash Flowderived$422,000—
Margins · derived
Operating margin-8.7%
Net margin-9.3%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q1 2010 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ernexa Therapeutics Inc. · CIK 748592 · Engraved from SEC EDGAR